Metronomic chemotherapy beyond misconceptions

被引：2
作者：
Hatzimichael, Eleftheria [1 ]
Briasoulis, Evangelos [1 ]
机构：
[1] Univ Hosp Ioannina, Dept Haematol, Ioannina, Greece
来源：
HAEMATOLOGICA | 2013年 / 98卷 / 11期
关键词：
metronomic therapy; chemotherapy; multiple myeloma; relapsed refractory; ONCOLOGY; CANCER; TRIAL;
D O I：
10.3324/haematol.2013.096917
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E145 / E145
页数：1
相关论文
共 11 条
  • [1] Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study
    Briasoulis, Evangelos
    Aravantinos, Gerasimos
    Kouvatseas, George
    Pappas, Periklis
    Biziota, Eirini
    Sainis, Ioannis
    Makatsoris, Thomas
    Varthalitis, Ioannis
    Xanthakis, Ioannis
    Vassias, Antonios
    Klouvas, George
    Boukovinas, Ioannis
    Fountzilas, George
    Syrigos, Kostantinos N.
    Kalofonos, Haralambos
    Samantas, Epaminontas
    [J]. BMC CANCER, 2013, 13
  • [2] Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
    Briasoulis, Evangelos
    Pappas, Periklis
    Puozzo, Christian
    Tolis, Christos
    Fountzilas, George
    Dafni, Urania
    Marselos, Marios
    Pavlidis, Nicholas
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (20) : 6454 - 6461
  • [3] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY
    FREI, E
    CANELLOS, GP
    [J]. AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) : 585 - 594
  • [4] Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice
    Hanahan, D
    Bergers, G
    Bergsland, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) : 1045 - 1047
  • [5] Hollmig K, 2004, ASH ANN M ABSTRACTS, V104, P2399
  • [6] The anti-angiogenic basis of metronomic chemotherapy
    Kerbel, RS
    Kamen, BA
    [J]. NATURE REVIEWS CANCER, 2004, 4 (06) : 423 - 436
  • [7] The Role of the US Food and Drug Administration Review Process: Clinical Trial Endpoints in Oncology
    McKee, Amy E.
    Farrell, Ann T.
    Pazdur, Richard
    Woodcock, Janet
    [J]. ONCOLOGIST, 2010, 15 : 13 - 18
  • [8] Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma
    Papanikolaou, Xenofon
    Szymonifka, Jackie
    Rosenthal, Adam
    Heuck, Christoph J.
    Mitchell, Alan
    Johann, Donald, Jr.
    Keller, Jason
    Waheed, Sarah
    Usmani, Saad Z.
    Van Rhee, Frits
    Bailey, Clyde
    Petty, Nathan
    Hoering, Antje
    Crowley, John
    Barlogie, Bart
    [J]. HAEMATOLOGICA, 2013, 98 (07) : 1147 - 1153
  • [9] Metronomic chemotherapy: new rationale for new directions
    Pasquier, Eddy
    Kavallaris, Maria
    Andre, Nicolas
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (08) : 455 - 465
  • [10] Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
    Rajkumar, S. Vincent
    Harousseau, Jean-Luc
    Durie, Brian
    Anderson, Kenneth C.
    Dimopoulos, Meletios
    Kyle, Robert
    Blade, Joan
    Richardson, Paul
    Orlowski, Robert
    Siegel, David
    Jagannath, Sundar
    Facon, Thierry
    Avet-Loiseau, Herve
    Lonial, Sagar
    Palumbo, Antonio
    Zonder, Jeffrey
    Ludwig, Heinz
    Vesole, David
    Sezer, Orhan
    Munshi, Nikhil C.
    San Miguel, Jesus
    [J]. BLOOD, 2011, 117 (18) : 4691 - 4695
12